[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

Clinical Expertise

  • Diffuse Large B Cell Lymphoma

About

Peter Riedell, MD, specializes in the care of adults with lymphomas and chronic lymphocytic leukemia. In particular, he has a special interest in the use of chimeric antigen receptor (CAR) T-cell therapy in the treatment of these conditions.

 

As a clinical researcher, Dr. Riedell serves as the principal investigator on several national and international clinical trials evaluating the role of targeted therapies, stem cell transplantation and cellular therapy in the treatment of lymphoma. He has been heavily involved in the development and implementation of therapies which harness a patient’s own immune system to fight cancer. His research aims to better characterize and enhance the safety and effectiveness of cellular therapy in order to improve patient outcomes.

Location

The University Of Chicago Medicine: 5841 S Maryland Ave, Chicago, IL 60637, USA

newsletter icon

Get the latest thought leadership on your Blood Cancer delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.